Table 1. Characteristics of the initial... | American Society of Hematology

Table 1.

Characteristics of the initial population of consecutive women from which the studied final groups of childless patients and controls were obtained after exclusion of those with thrombotic antecedents and/or biologic prothrombotic factors

	N	TA	AT	PC	PS	FVL	FIIL	aPLAb	HCY	PAI-1
Group 1
N	289	15	0	0	0	5	6	46	26	55
%		5.2	0	0	0	1.7	2.1	15.9	9	19
Group 2
N	312	27	0	1	12	20	13	51	23	27
%		8.7	0	0.3	3.9	6.4	4.2	16.4	7.4	8.7
Group 3
N	81	8	0	0	3	6	4	15	6	4
%		9.9	0	0	3.7	7.4	4.9	18.5	7.4	4.9
Control group
N	217	1	0	0	0	4	5	2	2	3
%		0.4	0	0	0	1.8	2.3	0.9	0.9	1.4

	N	TA	AT	PC	PS	FVL	FIIL	aPLAb	HCY	PAI-1
Group 1
N	289	15	0	0	0	5	6	46	26	55
%		5.2	0	0	0	1.7	2.1	15.9	9	19
Group 2
N	312	27	0	1	12	20	13	51	23	27
%		8.7	0	0.3	3.9	6.4	4.2	16.4	7.4	8.7
Group 3
N	81	8	0	0	3	6	4	15	6	4
%		9.9	0	0	3.7	7.4	4.9	18.5	7.4	4.9
Control group
N	217	1	0	0	0	4	5	2	2	3
%		0.4	0	0	0	1.8	2.3	0.9	0.9	1.4

Group 1, patients with 3 unexplained primary miscarriages before the 8th week of gestation; group 2, patients with one unexplained primary episode of early fetal death from the 10th to the end of the 19th week of gestation; group 3, patients with one unexplained primary episode of late fetal death from the beginning of the 20th week of gestation; control group, healthy mothers of one child. TA, thrombotic antecedents; AT, antithrombin deficiency; PC, protein C deficiency; PS, protein S deficiency; FVL, factor V Leiden mutation; FIIL, allele 20210A in the prothrombin gene; aPLAb, antiphospholipid/antiprotein antibodies; HCY, mild hyperhomocysteinemia; PAI-1, high plasminogen activator inhibitor 1 plasma levels; all these biologic data are according to previously published methods and results.6-9

View Large

This Feature Is Available To Subscribers Only